SCHEMBL5564378

SCHEMBL5564378

OCc1ncn(-c2nn(-c3ccccc3)c3ccccc23)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.48
SCN9A Q15858 3/20 0.35
HPGD P15428 5/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
HSD17B10 Q99714 2/20 0.35
USP2 O75604 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.34
LMNA P02545 3/20 0.34
RAB9A P51151 4/20 0.34
NPC1 O15118 3/20 0.34
ALOX15 P16050 2/20 0.34
TNF P01375 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
TSHR P16473 1/20 0.34
RARG P13631 2/20 0.34
RORC P51449 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5564055 0.82 CNR1 (0.48) PDE5AHPGDKDM4EALDH1A1MAPT
SCHEMBL5564053 0.78 PDE5A (0.50) PDE5ASCN9AHPGDKDM4EALDH1A1
SCHEMBL4886069 0.77 MAPT (0.47) HPGDKDM4EALDH1A1MAPTHSD17B10
SCHEMBL5558522 0.77 PDE5A (0.49) PDE5ASCN9AHPGDKDM4EALDH1A1
SCHEMBL5563395 0.75 PDE5A (0.47) PDE5ASCN9AHPGDKDM4EALDH1A1
SCHEMBL27834343 0.71 PDE5A (0.55) PDE5ASCN9AKDM4EALDH1A1MAPT
SCHEMBL5560161 0.71 PDE5A (0.49) PDE5ASCN9AHPGDKDM4EALDH1A1
SCHEMBL9681419 0.67 KDM4E (0.49) PDE5AKDM4EALDH1A1MAPTHSD17B10
SCHEMBL9680636 0.66 SMO (0.50) PDE5AHPGDKDM4EALDH1A1MAPT
SCHEMBL5558976 0.66 PDE5A (0.65) PDE5ASCN9AHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646382-A2 COMPOUNDS, COMPOSITIONS AND METHODS HIF BIO INC. (US) 2006-04-19 EP claimed
US-20050187276-A1 Compounds, compositions and methods BIZBIOTECH CO., LTD. (KR) 2005-08-25 US claimed
WO-2005030121-A2 COMPOUNDS, COMPOSITIONS AND METHODS HIF BIO, INC. (US) 2005-04-07 WO claimed
US-7226941-B2 Compound for treating angiogenesis HIF BIO, INC. (US) 2007-06-05 US disclosed
US-20050187276-A1 Compounds, compositions and methods BIZBIOTECH CO., LTD. (KR) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187276-A1 Compounds, compositions and methods HIF1A, HIF1AN, EGLN3 PDE5A 1987/4885SCN9A 4494/4885HPGD 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.